CEO and Co-founder, Coherence Bio

Coherence Bio aims to revolutionize the lab with our novel automation device and AI insights platform. Our integrated solution accelerates drug R&D, offering seamless automation with the touch of a button. The device enables sample-to-insight processing targeted at cell-based assays, a key part of the drug discovery process. Developed and crafted by an experienced team of hardware and software engineers, the robust technology platform can adapt to diverse lab protocols.